Stock ITOS ITEOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
16.74 USD -2.39% Intraday chart for iTeos Therapeutics, Inc. -5.32% +52.88%
May. 13 HC Wainwright Adjusts Price Target on iTeos Therapeutics to $46 From $44, Maintains Buy Rating MT
May. 10 Wedbush Adjusts iTeos Therapeutics' Price Target to $21 From $18, Maintains Outperform Rating MT

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : ITeos Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 03:00 PM
Transcript : ITeos Therapeutics, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 08:15 AM
Transcript : ITeos Therapeutics, Inc. Presents at Citi’s 2022 Virtual Immuno-Oncology Summit, Feb-17-2022 01:30 PM
Transcript : iTeos Therapeutics, Inc., Q3 2021 Earnings Call, Nov 10, 2021
Transcript : ITeos Therapeutics, Inc., Q2 2021 Earnings Call, Aug 12, 2021
Transcript : iTeos Therapeutics, Inc. - Special Call
Transcript : iTeos Therapeutics, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-12-2021 06:10 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ITOS Stock
  4. News iTeos Therapeutics, Inc.
  5. Transcripts